Literature DB >> 6325949

Activation of cellular gene by mouse mammary tumour virus may occur early in mammary tumour development.

G Peters, A E Lee, C Dickson.   

Abstract

There is now good evidence that the induction of mammary carcinomas by mouse mammary tumour virus (MMTV) involves provirus activation of specific cellular genes. Thus, a high percentage of virally induced tumours contain an acquired MMTV provirus in either of two defined integration regions, termed int-1 and int-2, and provirus insertion is accompanied by expression of specific RNA transcripts from these regions. We show here that in some recurring, pregnancy-dependent mammary tumours provirus integration within int-2 has already occurred at the earliest appearance of the tumour and may therefore represent an important step in the development of neoplasia. As judged by the distribution of the acquired MMTV proviruses, the tumours recurring at any one site represent the same clonal population of cells as the original tumour and remain clonal during cycles of proliferation and regression, including the transition to hormone-independent status. These data suggest that either the expression of the int-2 locus or the function of this putative oncogene must remain responsive to hormones and that some additional event must be responsible for the transition to autonomous growth.

Entities:  

Mesh:

Year:  1984        PMID: 6325949     DOI: 10.1038/309273a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  21 in total

Review 1.  Mouse chromosome 7.

Authors:  E M Rinchik; T Magnuson; B Holdener-Kenny; G Kelsey; A Bianchi; C J Conti; F Chartier; K A Brown; S D Brown; J Peters
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines.

Authors:  Albana Gattelli; María N Zimberlin; Roberto P Meiss; Lucio H Castilla; Edith C Kordon
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

Review 3.  Mouse chromosome 7.

Authors:  E M Rinchik; A M Saunders; B Holdener-Kenny; M J Sutcliffe; K A Brown; S D Brown; J Peters
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

4.  The progesterone receptor gene maps to human chromosome band 11q13, the site of the mammary oncogene int-2.

Authors:  M L Law; F T Kao; Q Wei; J A Hartz; G L Greene; T Zarucki-Schulz; O M Conneely; C Jones; T T Puck; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Monoclonal proliferation of Friend murine leukemia virus-transformed myeloblastic cells occurs early in the leukemogenic process.

Authors:  B Sola; J M Heard; S Fichelson; M A Martial; F Pozo; D Bordereaux; S Gisselbrecht
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

6.  Activation of int-1 and int-2 mammary oncogenes in hormone-dependent and -independent mammary tumors of GR mice.

Authors:  J Mester; E Wagenaar; M Sluyser; R Nusse
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

7.  Expression of the int-1 and int-2 loci in endogenous mouse mammary tumor virus-induced mammary tumorigenesis in the C3Hf mouse.

Authors:  P R Etkind
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

Review 8.  MMTV-induced pregnancy-dependent mammary tumors : early history and new perspectives.

Authors:  Edith C Kordon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-26       Impact factor: 2.673

9.  Sequences within the gag gene of mouse mammary tumor virus needed for mammary gland cell transformation.

Authors:  Ingrid Swanson; Brooke A Jude; Annie R Zhang; Andrew Pucker; Zachary E Smith; Tatyana V Golovkina
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.

Authors:  F S Lee; T F Lane; A Kuo; G M Shackleford; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.